GOT1 activity could be enhanced by tumor suppressor SIRT5 deletion via facilitating GOT1’s lysine acetylation to regulate the non-canonical Gln and glutathione metabolism, and then promoted tumorigenesis of Kras-induced pancreatic cancer (45). This evidence concerns the gene GOT1 and pancreatic neoplasm.